Thomas Strong is currently the Market Access Team Lead for Vaccines and Immune Therapies at AstraZeneca, a position held since 2023. From 2018 to 2022, Thomas served as the Interim Associate Director for Managed Access at NICE, where they led a multidisciplinary team on various managed access topics. Previously, Thomas worked as an HTA Adviser and Technical Analyst at NICE, focusing on health technology assessments and the development of real-world evidence. Thomas began their academic journey at the University of Bristol, earning a Bachelor of Science in Biochemistry, followed by a Master of Science in Molecular Neuroscience.
Location
London, United Kingdom
This person is not in the org chart
This person is not in any teams
This person is not in any offices